egnhs

EGNHS (EGS crosslinker) is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs[1].

m-PEG-NHS ester (MW 10000) is a PEG-based PROTAC linker used for synthesizing PROTACs[1].

rm-PEG-NHS ester (MW 20000) is a PEG-based PROTAC linker utilized for the synthesis of PROTACs[1].

m-PEG-NHS ester (MW 5000) is a PEG-based PROTAC linker utilized in the synthesis of PROTACs[1].

DSPE-PEG-NHS（MW 3400）is a PEGylated phospholipid derivative designed for advanced lipid formulation applications, particularly in the preparation of liposomes, where it enables efficient surface modification and functionalization, and is widely used as a delivery material for nucleic acid-based therapeutics such as DNA and mRNA vaccines, supporting research in drug delivery systems, nanomedicine, and vaccine formulation technologies.

DSPE-PEG-NHS (MW 2000), is a PEGylated phospholipid derivative containing a reactive N-hydroxysuccinimide (NHS) ester functional group. DSPE-PEG-NHS (MW 2000), is utilized in the fabrication of liposomes and lipid nanoparticles for the encapsulation and delivery of DNA and mRNA vaccines, improving stability, circulation time, and targeting capability of nucleic acid-based therapeutics.

m-PEG-NHS ester (MW 3400) can be used to modify active molecules, thereby enhancing their antigenicity and immunogenicity, which is beneficial for the preparation of injectable formulations. Its modification of serine protease lumbrokinase (LK) does not affect the enzyme’s strong fibrinolytic and thrombolytic activities, indicating promising application prospects.

m-PEG-NHS ester (MW 1000) can be used to modify active molecules and enhance their antigenicity and immunogenicity, which is beneficial for the preparation of injectable preparations. m-PEG-NHS ester modification of serine protease lumbrokinase (LK) does not affect its significant fibrinolytic and thrombolytic activities, showing good application prospects.

m-PEG-NHS ester (MW 550) is used to modify active molecules to enhance their antigenicity and immunogenicity, aiding in the preparation of injectable formulations. Modification with m-PEG-NHS ester does not affect the strong fibrinolytic and thrombolytic activities of the serine protease Lumbrokinase (LK), offering promising application potential.

m-PEG-NHS ester (MW 350) is utilized to modify active molecules, enhancing their antigenicity and immunogenicity, thus aiding in the preparation of injectable formulations. Modification of serine protease lumbrokinase (LK) with m-PEG-NHS ester does not affect its fibrinolytic and thrombolytic activities, indicating promising potential for application.

Acrylate-PEG-NHS (MW 2000) is a photosensitive PEG compound that undergoes crosslinking when exposed to UV light, making it suitable for the synthesis of PEG hydrogels.

Acrylate-PEG-NHS (MW 3500) is a photoreactive PEG compound that undergoes crosslinking when exposed to ultraviolet light, making it suitable for synthesizing PEG hydrogels.

Acrylate-PEG-NHS (MW 5000) is a photosensitive PEG compound that undergoes crosslinking when exposed to ultraviolet light, used in the synthesis of PEG hydrogels.

Azide-PEG-NHS (MW 3500)is an azide-terminated PEG NHS ester suitable for click chemistry reactions and the synthesis of PEG hydrogels.

Azide-PEG-NHS (Mn 5000) is an azide PEG NHS ester that is applicable in click chemistry reactions and in the synthesis of PEG hydrogels.

Cholesterol-PEG-NHS (MW 1000) is a functionalized lipid that conjugates with amine-containing biomolecules. It improves the encapsulation and circulation of proteins or nucleic acids in LNP research.

Cholesterol-PEG-NHS (MW 2000) is a cholesterol PEG derivative capable of forming micelles through molecular self-assembly and features an extended half-life in vivo. It is useful for research in drug delivery.

Cholesterol-PEG-NHS (MW 3400) is a cholesterol-based PEG derivative that can self-assemble into micelles and has an extended half-life in vivo. It is suitable for research in drug delivery.

Cholesterol-PEG-NHS (MW 5000) is a cholesterol PEG derivative capable of forming micelles through molecular self-assembly and demonstrates an extended half-life in vivo. This compound is applicable in research focused on drug delivery.

Stearic acid-PEG-NHS (MW 1000) is a phospholipid PEG polymer containing cyclooctyne. This polymer can spontaneously assemble into micelles or lipid bilayers in water. It is suitable for preparing nanoparticles or liposomes as drug carriers in targeted drug delivery systems. DBCO can react with azide molecules via copper-free click chemistry to form stable triazole bonds. Reagent grade, for research use only.

Stearic acid-PEG-NHS (MW 3400) is a phospholipid poly PEG that can self-assemble into lipid bilayers in water. This polymer is utilized for preparing liposomes, which serve as drug carriers for delivering nutrients or therapeutic agents such as mRNA or DNA. Reagent grade, intended for research use only.

DSPE-PEG-NHS, MW 600, is a PEG-modified phospholipid derivative used in liposome preparation for the delivery of DNA or mRNA vaccines.

DSPE-PEG-NHS, with a molecular weight of 1,000, is an amine-reactive phospholipid. The reaction between the NHS ester and an amine results in a stable amide bond. This polymer is amphiphilic, enabling it to form micelles or lipid bilayers in aqueous solutions.

DSPE-m-PEG-NHS (MW 3400) is a PEGylated phospholipid derivative employed in the preparation of liposomes for the delivery of DNA or mRNA vaccines.